awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37191934-78A64AE5-F615-43AA-9C89-7577291F8DBF
Q37191934-78A64AE5-F615-43AA-9C89-7577291F8DBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37191934-78A64AE5-F615-43AA-9C89-7577291F8DBF
Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2
P2860
Q37191934-78A64AE5-F615-43AA-9C89-7577291F8DBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37191934-78A64AE5-F615-43AA-9C89-7577291F8DBF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b389c532477c0d69c6dd65f4983126eebf42ee6
P2860
In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption